We show here that high levels of nuclear ARRB1 in prostate cancer cells result in downregulation of FH and SDHA expression, although this effect is likely to be an indirect consequence as our genomics analysis did not identify any ARRB1-binding sites in the promoter regions of these two genes. The gene discussed is ARRB1; the disease is prostate carcinoma.